Safety of dual biological therapy in Crohn’s disease: a case series of vedolizumab in combination with other biologics

Uncertainty exists regarding safety and efficacy of dual biological therapy (DBT) in inflammatory bowel disease. We present four cases of DBT in Crohn’s disease. Three patients had refractory disease non-responsive to biological monotherapy or combination therapy with immunomodulators. One patient h...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open Gastroenterol
Autors principals: Mao, Eric J, Lewin, Sara, Terdiman, Jonathan P, Beck, Kendall
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2018
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6254738/
https://ncbi.nlm.nih.gov/pubmed/30538822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2018-000243
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars